Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Humana Inc (NYSE: HUM) was $275.80 for the day, down -1.32% from the previous closing price of $279.49. In other words, the price has decreased by -$1.32 from its previous closing price. On the day, 1.51 million shares were traded. HUM stock price reached its highest trading level at $279.32 during the session, while it also had its lowest trading level at $268.46.
Ratios:
Our analysis of HUM’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 06, 2024, Upgraded its rating to Neutral and sets its target price to $308 from $247 previously.
Bernstein Upgraded its Mkt Perform to Outperform on October 08, 2024, while the target price for the stock was maintained at $308.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 31 ’24 when Huval Timothy S. sold 3,703 shares for $256.26 per share. The transaction valued at 948,925 led to the insider holds 8,181 shares of the business.
Huval Timothy S. bought 3,703 shares of HUM for $938,433 on Dec 31 ’24. On Dec 06 ’24, another insider, William K. Fleming, who serves as the Officer of the company, bought 8,661 shares for $283.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 33209352192 and an Enterprise Value of 22497447936. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.42, and their Forward P/E ratio for the next fiscal year is 16.37. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 1.89. Its current Enterprise Value per Revenue stands at 0.196 whereas that against EBITDA is 5.953.
Stock Price History:
The Beta on a monthly basis for HUM is 0.55, which has changed by -0.31312728 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $455.53, while it has fallen to a 52-week low of $213.31. The 50-Day Moving Average of the stock is 0.57%, while the 200-Day Moving Average is calculated to be -13.24%.
Shares Statistics:
HUM traded an average of 1.89M shares per day over the past three months and 1340530 shares per day over the past ten days. A total of 120.41M shares are outstanding, with a floating share count of 120.14M. Insiders hold about 0.23% of the company’s shares, while institutions hold 96.03% stake in the company. Shares short for HUM as of 1735603200 were 5581342 with a Short Ratio of 2.95, compared to 1732838400 on 4529482. Therefore, it implies a Short% of Shares Outstanding of 5581342 and a Short% of Float of 4.64.
Dividends & Splits
With its trailing 12-month dividend rate of 3.54, HUM has a forward annual dividend rate of 3.54. Against a Trailing Annual Dividend Yield of 0.012665927The stock’s 5-year Average Dividend Yield is 0.73. The current Payout Ratio is 17.70% for HUM, which recently paid a dividend on 2024-12-31 with an ex-dividend date of 1735603200. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
